Special Issue "Advances in Nanostructured Biomaterials and Their Applications, Volume II"

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: 20 November 2023 | Viewed by 1790

Special Issue Editor

Materials Science, Duke Kunshan University, Kunshan 215316, China
Interests: development of high performance nanostructured and nanocomposite materials based on superthin/thin/thick films using novel and advanced materials synthesis methods for solar cells; energy storage; optoelectronics applications; non-vacuum Chemical Vapour Deposition technology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The design and engineering of biomaterials at the nanoscale has transformed nanostructured biomaterials with unique properties for real-world applications, including therapeutic, tissue engineering, drug/cell/gene delivery, imaging, medical implants, and diagnostics.

This Special Issue aims to publish original, innovative, cutting edge, and ground-breaking nanostructured biomaterials research. This includes communications and review articles, covering advances in the fundamental understanding, development, and applications of nanostructured biomaterials obtained through experimental, theoretical, and/or modelling approaches, addressing the current limitations, challenges, and outlook in this field towards practical industry, healthcare, and biomedical applications.

We invite contributions to this Special Issue which revolve around, but are not limited to, the following topics:

  • Novel nanostructured biomaterials applied in 1D, 2D, 3D, and/or coatings and their applications, including sensing, healthcare, biomedical research, or tissue engineering;
  • Nanoengineered biomaterials, including bioactive and/or biodegradable materials;
  • Sustainable and cost-effective fabrication of nanostructured biomaterials, including bionanocomposites;
  • Functionalization and/or nano-surface engineering of biomaterials;
  • Improvement in characterization and clinical testing of nanostructured biomaterials;
  • Interaction of nanostructured biomaterials with biological molecules such as proteins/enzymes, DNA, RNA, antibodies, etc.;
  • Surface and interface control in nanostructured biomaterials;
  • Intelligent (smart), biomimetic nanostructured biomaterials and their applications.

Prof. Dr. Kwang Leong Choy
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • nanoengineered biomaterials
  • bioactive coatings
  • intelligent biomaterials
  • bionanocomposites
  • biodegradable materials
  • surface modification
  • biomedical applications

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review
Nanomaterials 2022, 12(19), 3323; https://doi.org/10.3390/nano12193323 - 24 Sep 2022
Cited by 10 | Viewed by 1704
In recent years, gene therapy has made remarkable achievements in tumor treatment. In a successfully cancer gene therapy, a smart gene delivery system is necessary for both protecting the therapeutic genes in circulation and enabling high gene expression in tumor sites. Magnetic iron [...] Read more.
In recent years, gene therapy has made remarkable achievements in tumor treatment. In a successfully cancer gene therapy, a smart gene delivery system is necessary for both protecting the therapeutic genes in circulation and enabling high gene expression in tumor sites. Magnetic iron oxide nanoparticles (IONPs) have demonstrated their bright promise for highly efficient gene delivery target to tumor tissues, partly due to their good biocompatibility, magnetic responsiveness, and extensive functional surface modification. In this review, the latest progress in targeting cancer gene therapy is introduced, and the unique properties of IONPs contributing to the efficient delivery of therapeutic genes are summarized with detailed examples. Furthermore, the diagnosis potentials and synergistic tumor treatment capacity of IONPs are highlighted. In addition, aiming at potential risks during the gene delivery process, several strategies to improve the efficiency or reduce the potential risks of using IONPs for cancer gene therapy are introduced and addressed. The strategies and applications summarized in this review provide a general understanding for the potential applications of IONPs in cancer gene therapy. Full article
Show Figures

Figure 1

Back to TopTop